`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`COPY
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`Alcs,Virgin 22313-1450
`
`18/068,418
`
`12/19/2022
`
`OPAP
`
`5000
`
`13565
`
`DonirsUSLP
`
`Suite 700
`San Diego, CA 92121
`
`1
`35
`33320.03087.US2E/3087K
`CONFIRMATIONNO. 5769
`REPLACEMENT FILING RECEIPT
`
`LT
`
`Date Mailed: 04/28/2023
`
`Receipt is acknowledged of this non-provisional utility patent application. The application will be taken up for
`examination in due course. Applicant will be notified as to the results of the examination. Any correspondence
`concerning the application must include the following identification information: the U.S. APPLICATION NUMBER,
`FILING DATE, NAME OF FIRST INVENTOR, and TITLE OF INVENTION. Fees transmitted by check or draft are
`subject to collection.
`
`Pleaseverify the accuracy of the data presented on this receipt. If an error is noted on this Filing Receipt, please
`submit a written request for a corrected Filing Receipt, including a properly marked-up ADS showing the changes
`with strike-through for deletions and underlining for additions. If you received a "Notice to File Missing Parts" or
`other Notice requiring a responsefor this application, please submit any request for correction to this Filing Receipt
`with your reply to the Notice. When the USPTO processesthe reply to the Notice, the USPTO will generate another
`Filing Receipt incorporating the requested corrections provided that the requestis grantable.
`
`Inventor(s)
`
`Applicant(s)
`
`Ge Wei, San Diego, CA;
`H. Michael Shepard, Eugene, OR;
`Qiping Zhao, San Diego, CA;
`Robert James Connor, Oceanside, CA;
`
`Halozyme, Inc., San Diego, CA;
`
`Power of Attorney:
`STEPHANIE SEIDMAN -33779
`FRANK MISKIEL -53332
`
`JOSHLAGALGANG—7~4802- JAMES M. TURNER - 74602
`
`Domestic Priority data as claimed by applicant
`This application is a DIV of 17/827,568 05/21/2021
`which is a CON of 16/912,590 06/25/2020 PAT 11,066,656
`which is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`and said 17/327,568 05/21/2021 is a CON of 16/824,572 03/19/2020 PAT 11,041,149
`which is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`page 1 of 5
`
`

`

`COPY
`
`and claims benefit of 61/631,313 12/30/2011
`and said 17/327,568 05/21/2021 is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`and claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`This application is a DIV of 17/327,586 05/21/2021
`which is a CON of 16/912,590 06/25/2020 PAT 11,066,656
`which is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`and said 17/327,586 05/21/2021 is a CON of 16/824,572 03/19/2020 PAT 11,041,149
`which is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`and said 17/327,586 05/21/2021 is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`and said 17/327,586 05/21/2021 is a CON of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`This application is a DIV of 16/912,590 06/25/2020 PAT 11,066,656
`which is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`and said 16/912,590 06/25/2020 is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`This application is a DIV of 16/824,572 03/19/2020 PAT 11,041,149
`which is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`and said 16/824,572 03/19/2020 is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`This application is a CON of 15/226,489 08/02/2016 PAT 10,865,400
`which is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`This application is a DIV of 13/694,731 12/28/2012 PAT 9,447,401
`which claims benefit of 61/796,208 11/01/2012
`and claims benefit of 61/631,313 12/30/2011
`
`Foreign Applications for which priority is claimed (You may beeligible to benefit from the Patent Prosecution
`Highwayprogram at the USPTO. Please see http:/Awww.uspto.gov for more information.) - None.
`Foreign application information must be provided in an Application Data Sheetin order to constitute a claim to
`foreign priority. See 37 CFR 1.55 and 1.76.
`
`page 2 of 5
`
`

`

`COPY
`
`Permission to Access Application via Priority Document Exchange: Yes
`
`Permission to Access Search Results: Yes
`
`Applicant may provide or rescind an authorization for access using Form PTO/SB/39 or Form PTO/SB/69 as
`appropriate.
`
`If Required, Foreign Filing License Granted: 03/29/2023
`
`The country code and number of your priority application, to be used for filing abroad under the Paris Convention,
`is US 18/068,418
`
`Projected Publication Date: 07/06/2023
`
`Non-Publication Request: No
`
`Early Publication Request: No
`Title
`
`PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
`
`Preliminary Class
`424
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition Applications: No
`
`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a U.S. patent extend only throughout the territory of the United States and have no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in a specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application under the Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies the filing
`of patent applications on the same invention in member countries, but does not result in a grant of "an international
`patent" and does noteliminate the need of applicants to file additional documents and fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and a person desiring a patent in a particular country must make an
`application for patent in that country in accordance with its particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries to ensure that patent rights are not lost prematurely.
`
`Applicants also are advised that in the case of inventions made in the United States, the Director of the USPTO must
`issue a license before applicants can apply for a patent in a foreign country. The filing of a U.S. patent application
`serves as a request for a foreign filing license. The application's filing receipt contains further information and
`guidanceas to the status of applicant's license for foreign filing.
`
`Applicants may wish to consult the USPTO booklet, "General Information Concerning Patents" (specifically, the
`section entitled "Treaties and Foreign Patents") for more information on timeframes and deadlinesfor filing foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 800-786-9199, or it
`can be viewed on the USPTOwebsite at http://www.uspto.gov/web/offices/pac/doc/general/index.html.
`
`page 3 of 5
`
`

`

`COPY
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the U.S. Government website, http:/Awww.stopfakes.gov. Part of a Department of Commerceinitiative,
`this website includes self-help “toolkits” giving innovators guidance on how to protectintellectual property in specific
`countries such as China, Korea and Mexico. For questions regarding patent enforcement issues, applicants may
`call the U.S. Government hotline at 1-866-999-HALT (1-866-999-4258).
`
`LICENSE FOR FOREIGN FILING UNDER
`
`Title 35, United States Code, Section 184
`
`Title 37, Code of Federal Regulations, 5.11 & 5.15
`
`GRANTED
`
`The applicant has been granted a license under 35 U.S.C. 184, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED"followed by a date appears on this form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whether or not a license may be required as
`set forth in 37 CFR 5.15. The scope and limitations of this license are set forth in 37 CFR 5.15(a) unless an earlier
`license has been issued under 37 CFR 5.15(b). The license is subject to revocation upon written notification. The
`date indicated is the effective date of the license, unless an earlier license of similar scope has been granted under
`37 CFR 5.13 or 5.14.
`
`This license is to be retained by the licensee and may be usedat any time onor after the effective date thereof unless
`it is revoked. This license is automatically transferred to any related applications(s) filed under 37 CFR 1.53(d). This
`license is not retroactive.
`
`The grant of a license does notin any way lessen the responsibility of a licensee for the security of the subject matter
`as imposed by any Government contract or the provisions of existing laws relating to espionage and the national
`security or the export of technical data. Licensees should apprise themselvesof current regulations especially with
`respect to certain countries, of other agencies, particularly the Office of Defense Trade Controls, Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121-128)); the Bureau of Industry and
`Security, Department of Commerce (15 CFR parts 730-774); the Office of Foreign AssetsControl, Department of
`Treasury (31 CFR Parts 500+) and the Department of Energy.
`
`
`
`NOTGRANTED
`
`No license under 35 U.S.C. 184 has been grantedat this time, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED" DOES NOTappear on this form. Applicant maystill petition for a license under 37 CFR 5.12,
`if a license is desired before the expiration of 6 months from the filing date of the application. If 6 months has lapsed
`from the filing date of this application and the licensee has not received any indication of a secrecy order under 35
`U.S.C. 181, the licensee mayforeign file the application pursuant to 37 CFR 5.15(b).
`
`
`SelectUSA
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location for
`business investment, innovation, and commercialization of new technologies. The U.S. offers tremendous resources
`and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation works to
`promote and facilitate business investment. SelectUSA provides information assistance to the international investor
`
`page 4 of 5
`
`

`

`COPY
`
`community; serves as an ombudsman for existing and potential investors; advocates on behalf of U.S. cities, states,
`and regions competing for global investment; and counsels U.S. economic development organizations on investment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology, manufacture products, deliver services, and grow your business, visit http:/Avwww.SelectUSA.govor call
`+1-202-482-6800.
`
`page 5 of 5
`
`